Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial
Article in International Immunopharmacology (December 2022)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
Article in Critical Care Explorations (August 2021)
Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis
Article in Journal of Personalized Medicine (July 2021)